Skip to content

Clinical trials

Completed Schizophrenia trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Serbia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20072
20082
20093
20101
20114
20122
20131
20151
20165
20173
20192
20202
20215
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.10
ACADIA Pharmaceuticals Inc.3
Alkermes, Inc.3
H. Lundbeck A/S3
Sumitomo Pharma America, Inc.3
AstraZeneca2
Boehringer Ingelheim2
FORUM Pharmaceuticals Inc2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Clinic for Psychiatric Disorders, Dr Laza Lazarevic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia37
Psychotic Disorders2
Bipolar Disorder1
Central Nervous System Diseases1
Cognition Disorders1
Cognitive Dysfunction1
Recurrence1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.